Ru(ii)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells-Reference-Cited by-同舟云学术

Ru(ii)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells

Published:2020 Issue:36 Volume:49 Page:12643-12652
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Oliveira Katia M.¹²³⁴⁵^ORCID,Honorato João¹⁶⁷⁵^ORCID,Gonçalves Guilherme R.¹²³⁴⁵,Cominetti Marcia R.⁸⁶⁷⁵^ORCID,Batista Alzir A.¹⁶⁷⁵^ORCID,Correa Rodrigo S.¹²³⁴⁵^ORCID

Affiliation:

1. Departamento de Química

2. ICEB

3. Universidade Federal de Ouro Preto (UFOP)

4. Ouro Preto

5. Brazil

6. Universidade Federal de São Carlos (UFSCar)

7. São Carlos

8. Departamento de Gerontologia

Abstract

The well-known anti-inflammatory drug diclofenac can form new ruthenium compounds with promising anti-tumor properties.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/DT/D0DT01591A

Reference50 articles.

1. Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium

2. Stimuli-Responsive Therapeutic Metallodrugs

3. Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery

4. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: RATIONALE FOR USE IN SEVERE POSTOPERATIVE PAIN

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Ru(II)/benzoate complexes against triple-negative breast tumor cells and their interactions with DNA and BSA;Inorganica Chimica Acta;2024-08

2. Diclofenac derivatives as promising anticancer and anti-inflammatory drug: Synthesis, formulations, and pharmacokinetics;Journal of Drug Delivery Science and Technology;2024-05

3. Insight into the anti-proliferation activity and photoinduced NO release of four nitrosylruthenium isomeric complexes and their HSA complex adducts;Metallomics;2024-01-23

4. Heterocyclic (pyrazine)carboxamide Ru(ii) complexes: structural, experimental and theoretical studies of interactions with biomolecules and cytotoxicity;RSC Advances;2024

5. Exploring the potential of ruthenium(ii)–phosphine–mercapto complexes as new anticancer agents;Dalton Transactions;2024